US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist
  • 4.455
  • +0.405+10.00%
Trading Apr 23 12:36 ET
216.74MMarket Cap-3324P/E (TTM)

About Elevation Oncology Company

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.

Company Profile

SymbolELEV
Company NameElevation Oncology
Listing DateJun 25, 2021
Issue Price16.00
Founded2019
CEOMr. Joseph J. Ferra, Jr
MarketNASDAQ
Employees29
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address101 Federal Street,12th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-716-371-1125
Websitehttp://www.elevationoncology.com

Company Executives

  • Name
  • Position
  • Salary
  • Joseph J. Ferra, Jr
  • President, Chief Executive Officer and Director
  • --
  • Tammy Furlong
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. David Dornan, PhD
  • Chief Scientific Officer
  • 851.37K
  • Valerie Malyvanh Jansen
  • Chief Medical Officer
  • 793.30K
  • Steven A. Elms
  • Chairman of the Board
  • 91.15K
  • Dr. Alan B. Sandler, M.D.
  • Director
  • --
  • Julie M. Cherrington, PhD
  • Director
  • --
  • R. Michael Carruthers
  • Independent Director
  • 67.15K
  • Dr. Darcy Mootz, PhD
  • Independent Director
  • --
  • Dr. Timothy P. Clackson,PhD
  • Independent Director
  • 65.15K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg